PRELUDE CAPITAL MANAGEMENT, LLC

Position in PFE — Pfizer Inc

CIK 1387508 NEW YORK, NY

Back to PFE Full portfolio

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,835,323

-$934,473 QoQ

Shares Held

117,746

-12.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#817

of 2,820 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Jun 30, 2021

CallValue

$285,868

CallShares

7,300

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $9,540,290 across 6 Drug Manufacturers - General names. PFE ranks #2 (29.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,543	$3,050,150
2	PFE	Pfizer Inc This page	117,746	$2,835,323
3	OGN	Organon & Co.	183,473	$2,484,224
4	GILD	Gilead Sciences, Inc.	4,684	$591,776
5	JNJ	Johnson & Johnson	1,370	$347,938
6	NVO	Novo Nordisk A S	4,816	$230,879

All Filings in PFE

Export CSV

31 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,835,323	117,746	-12.3%	Shares	Other	2026-08-14
2026-03-31	$3,769,796	134,252	+12.7%	Shares	Other	2026-05-15
2025-12-31	$2,966,635	119,142	+422.0%	Shares	Other	2026-02-17
2025-09-30	$581,530	22,823	+48.1%	Shares	Other	2025-11-14
2025-06-30	$373,489	15,408	-82.8%	Shares	Other	2025-08-14
2025-03-31	$2,276,393	89,834	+29.6%	Shares	Other	2025-05-15
2024-12-31	$1,839,351	69,331	+21.5%	Shares	Other	2025-02-14
2024-09-30	$1,651,576	57,069	+2.6%	Shares	Other	2024-11-14
2024-06-30	$1,556,303	55,622	+0.0%	Shares	Other	2024-08-14
2024-03-31	$1,543,427	55,619	-15.5%	Shares	Other	2024-05-15
2023-12-31	$1,895,274	65,831	+544.2%	Shares	Other	2024-02-14
2023-09-30	$338,964	10,219	+12.0%	Shares	Other	2023-11-14
2023-06-30	$334,631	9,123	+25.2%	Shares	Other	2023-08-14
2023-03-31	$297,268	7,286	-52.8%	Shares	Other	2023-06-01
2022-12-31	$790,838	15,434	-58.7%	Shares	Other	2023-02-14
2022-09-30	$1,633,560	37,330	+101.0%	Shares	Other	2022-11-14
2022-06-30	$973,887	18,575	-57.5%	Shares	Other	2022-08-24
2022-03-31	$2,260,692	43,668	-34.0%	Shares	Other	2022-05-16
2021-12-31	$3,908,401	66,188	+157.3%	Shares	Other	2022-02-14
2021-09-30	$1,106,389	25,724	+342.1%	Shares	Sole	2021-11-15
2021-06-30	$227,872	5,819	-87.3%	Shares	Sole	2021-08-16
2021-06-30	$285,868	7,300	-52.9%	Call	Sole	2021-08-16
2021-03-31	$561,565	15,500	-73.3%	Call	Other	2021-05-17
2021-03-31	$1,665,239	45,963	+331.2%	Shares	Other	2021-05-17
2021-03-31	$7,256,869	200,300	-0.3%	Put	Other	2021-05-17
2020-12-31	$392,394	10,660	+41.6%	Shares	Other	2021-02-16
2020-12-31	$7,398,810	201,000	—	Put	Other	2021-02-16
2020-12-31	$2,134,980	58,000	+1971.4%	Call	Other	2021-02-16
2020-09-30	$276,314	7,529	—	Shares	Other	2020-11-16
2020-06-30	$91,560	2,800	-22.2%	Call	Other	2020-08-14
2020-03-31	$117,503	3,600	—	Call	Other	2020-05-15
No filing history on record for this holder in this stock.